N.Z. premier suggests desire for U.S. involvement in regional blocs

N.Z. premier suggests desire for U.S. involvement in regional blocs

TOKYO, Japan - Visiting New Zealand Prime Minister John Key speaks during a news conference in Tokyo on Oct. 30, 2009, a day after meeting with Japanese Prime Minister Yukio Hatoyama. Key indicated that it would be preferable if the United States is included in regional blocs such as the one advocated by Hatoyama.

  • Product Code
  • ILEA001138282
  • Registered date
  • 2009/10/30 00:00:00
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • 2009 Kyodo News
  • Media size
  • 1303 × 1671 pixel
  • Resolution
  • 240 dpi
  • Deployment size
  • 533.49(KB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    Japan PM Ishiba holds talks with business leaders

    Japan PM Ishiba holds talks with business leaders

    Japanese Prime Minister Shigeru Ishiba (far R) holds talks with (from far L) Takeshi Niinami, chairman of the Japan Association of Corporate Executives, Ken Kobayashi, chairman of the Japan Chamber of Commerce and Industry, and Masakazu Tokura, chairman of the Japan Business Federation, at the premier's office in Tokyo on Oct. 4, 2024.
      Japan PM Ishiba holds talks with business leaders

      Japan PM Ishiba holds talks with business leaders

      Takeshi Niinami (L), chairman of the Japan Association of Corporate Executives, Ken Kobayashi (R), chairman of the Japan Chamber of Commerce and Industry, and Masakazu Tokura, chairman of the Japan Business Federation, meet the press at the premier's office in Tokyo on Oct. 4, 2024, after holding talks with Japanese Prime Minister Shigeru Ishiba.
        Dollar soars to mid-146 yen level

        Dollar soars to mid-146 yen level

        A man passes by a financial monitor in Tokyo on Oct. 3, 2024, showing the U.S. dollar spurting to the mid-146 yen level, up about 2 yen from the previous day, after new Japanese Prime Minister Shigeru Ishiba expressed a cautious stance toward further credit tightening by the Bank of Japan.
          Japan top court orders damages for forced sterilization

          Japan top court orders damages for forced sterilization

          Japanese Prime Minister Fumio Kishida speaks to reporters at the premier's office in Tokyo on July 3, 2024, over the Supreme Court's order earlier in the day to the government to pay damages to plaintiffs who were forced to undergo sterilization surgery in the 1950s to 1970s under a now-defunct eugenics protection law.

            International conference on Osaka expo

            OSAKA, Japan Kyodo - Attendees pose for a photo on the first day of a two-day international conference on the Osaka expo in Osaka on Nov. 14, 2023. The Japan Association for the 2025 World Exposition held the meeting to provide information on the expo's pavilions for countries and international organizations planning to participate. (Kyodo)
              Japan, U.S. business leaders begin annual meeting in Tokyo

              Japan, U.S. business leaders begin annual meeting in Tokyo

              Japanese Prime Minister Fumio Kishida speaks on the first day of a two-day joint meeting of the Japan-U.S. Business Council and U.S.-Japan Business Council in Tokyo on Oct. 3, 2023.
                New BOJ governor Ueda

                New BOJ governor Ueda

                Japanese Prime Minister Fumio Kishida (R) and new Bank of Japan governor Kazuo Ueda shake hands before holding talks at the premier's office in Tokyo on April 10, 2023.
                  U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

                  U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

                  Japanese pharmaceutical maker Eisai Co. CEO Haruo Naito holds a press conference in Tokyo on Jan. 7, 2023, a day after the U.S. Food and Drug Administration approved lecanemab, an Alzheimer's drug developed by his company and U.S. firm Biogen Inc. for treatment in the early stage of the fatal, brain-robbing disease.
                    U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

                    U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

                    Japanese pharmaceutical maker Eisai Co. CEO Haruo Naito holds a press conference in Tokyo on Jan. 7, 2023, a day after the U.S. Food and Drug Administration approved lecanemab, an Alzheimer's drug developed by his company and U.S. firm Biogen Inc. for treatment in the early stage of the fatal, brain-robbing disease.
                      U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

                      U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

                      Japanese pharmaceutical maker Eisai Co. CEO Haruo Naito holds a press conference in Tokyo on Jan. 7, 2023, a day after the U.S. Food and Drug Administration approved lecanemab, an Alzheimer's drug developed by his company and U.S. firm Biogen Inc. for treatment in the early stage of the fatal, brain-robbing disease.